Jinhong Tablet Reduces Damage of Intestinal Mucosal Barrier in Rats with Acute Biliary Infection via Bcl-2/Bax mRNA and Protein Regulation
OBJECTIVE: To explore the effects and mechanism of Jinhong Tablet on intestinal mucosal barrier function and SIRS in rats with acute biliary infection.
METHODS: 36 SD male rats were divided into three groups: sham operation (control), acute biliary infection (ABI) model, and Jinhong Tablet (Jinhong) group. Jinhong group were force-fed with Jinhong Tablet, while the other two groups received oral saline. At days 3 and 5, morphological changes of intestinal mucosa were assessed. Serum diamine oxidase (DAO), D-lactate, and endotoxin levels were measured. And the genes bcl-2 and bax in intestinal tissues were tested by real-time PCR and Western blotting.
RESULTS: Intestinal damage was significantly less severe in Jinhong group compared with ABI group, as indicated by Chiu's scoring, TUNEL analysis, and serum DAO, D-lactic acid, and endotoxin levels. Additionally, the expression of bax mRNA and protein was decreased and the ratio of bcl-2/bax mRNA and protein was increased compared with ABI group.
CONCLUSION: Jinhong Tablet had a positive intervention on acute biliary infection through improving inflammation and intestinal mucosal barrier, inhibiting excessive apoptosis of intestinal epithelial cells via bax and bcl-2 gene, and protein regulation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2017 |
---|---|
Enthalten in: |
Evidence-based complementary and alternative medicine : eCAM - 2017(2017) vom: 03., Seite 4985926 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Liang, Xiaoqiang [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 11.03.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1155/2017/4985926 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM278991572 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM278991572 | ||
003 | DE-627 | ||
005 | 20231225021927.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1155/2017/4985926 |2 doi | |
028 | 5 | 2 | |a pubmed24n0929.xml |
035 | |a (DE-627)NLM278991572 | ||
035 | |a (NLM)29234407 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Liang, Xiaoqiang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Jinhong Tablet Reduces Damage of Intestinal Mucosal Barrier in Rats with Acute Biliary Infection via Bcl-2/Bax mRNA and Protein Regulation |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 11.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a OBJECTIVE: To explore the effects and mechanism of Jinhong Tablet on intestinal mucosal barrier function and SIRS in rats with acute biliary infection | ||
520 | |a METHODS: 36 SD male rats were divided into three groups: sham operation (control), acute biliary infection (ABI) model, and Jinhong Tablet (Jinhong) group. Jinhong group were force-fed with Jinhong Tablet, while the other two groups received oral saline. At days 3 and 5, morphological changes of intestinal mucosa were assessed. Serum diamine oxidase (DAO), D-lactate, and endotoxin levels were measured. And the genes bcl-2 and bax in intestinal tissues were tested by real-time PCR and Western blotting | ||
520 | |a RESULTS: Intestinal damage was significantly less severe in Jinhong group compared with ABI group, as indicated by Chiu's scoring, TUNEL analysis, and serum DAO, D-lactic acid, and endotoxin levels. Additionally, the expression of bax mRNA and protein was decreased and the ratio of bcl-2/bax mRNA and protein was increased compared with ABI group | ||
520 | |a CONCLUSION: Jinhong Tablet had a positive intervention on acute biliary infection through improving inflammation and intestinal mucosal barrier, inhibiting excessive apoptosis of intestinal epithelial cells via bax and bcl-2 gene, and protein regulation | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Ni, Xiao |e verfasserin |4 aut | |
700 | 1 | |a Wang, YongQi |e verfasserin |4 aut | |
700 | 1 | |a Xie, Jinkun |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xuelin |e verfasserin |4 aut | |
700 | 1 | |a Gu, Honggang |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jingzhe |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Evidence-based complementary and alternative medicine : eCAM |d 2004 |g 2017(2017) vom: 03., Seite 4985926 |w (DE-627)NLM149409524 |x 1741-427X |7 nnns |
773 | 1 | 8 | |g volume:2017 |g year:2017 |g day:03 |g pages:4985926 |
856 | 4 | 0 | |u http://dx.doi.org/10.1155/2017/4985926 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2017 |j 2017 |b 03 |h 4985926 |